SCHEMBL6948239

SCHEMBL6948239

N#Cc1c(OCC(F)(F)F)nc(CO)nc1N1CCc2ccccc2CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.39
ALDH1A1 P00352 10/20 0.37
KDM4E B2RXH2 7/20 0.37
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
HTT P42858 5/20 0.37
HPGD P15428 4/20 0.37
MAPT P10636 4/20 0.37
HSD17B10 Q99714 3/20 0.37
TP53 P04637 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
MAPK1 P28482 2/20 0.35
LMNA P02545 3/20 0.35
GAA P10253 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
KHK P50053 2/20 0.35
TSHR P16473 1/20 0.34
HIF1A Q16665 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
POLB P06746 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950700 0.92 PIK3CD (0.38) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6957307 0.88 LMNA (0.44) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6955400 0.88 PIK3CD (0.38) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6945764 0.85 PIK3CD (0.37) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6956303 0.85 KDM4E (0.41) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6950069 0.85 KDM4E (0.42) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6945704 0.83 GRIN2D (0.41) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6949294 0.82 KDM4E (0.43) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6947632 0.82 PIK3CD (0.39) PIK3CDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6954057 0.82 ALDH1A1 (0.39) PIK3CDALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed